After 3 weeks of administration, the Ad-GLP-1-hUC-MSC group and the Ad-GFP-hUC-MSC group were able to improve blood glucose and glucose tolerance in type 2 diabetic mice compared with the model group. This evidence concerns the gene GCG and type 2 diabetes mellitus.